Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis
Abstract Background Although conventional wisdom suggests that low socioeconomic status (SES) is a robust predictor of medication nonadherence, the strength of this association remains unclear. Objectives 1) To estimate the proportion of studies that identified SES as a potential risk indicator of n...
Gespeichert in:
Veröffentlicht in: | Value in health 2014-03, Vol.17 (2), p.288-296 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 296 |
---|---|
container_issue | 2 |
container_start_page | 288 |
container_title | Value in health |
container_volume | 17 |
creator | Alsabbagh, M.H.D. Wasem, BSc Lemstra, Mark, PhD Eurich, Dean, PhD Lix, Lisa M., PhD Wilson, Thomas W., MD Watson, Erin, MLIS Blackburn, David F., PharmD |
description | Abstract Background Although conventional wisdom suggests that low socioeconomic status (SES) is a robust predictor of medication nonadherence, the strength of this association remains unclear. Objectives 1) To estimate the proportion of studies that identified SES as a potential risk indicator of nonadherence, 2) to describe the type of SES measurements, and 3) to quantify the association between SES and nonadherence to antihypertensive pharmacotherapy. Methods A systematic review and meta-analysis research design was used. We searched multiple electronic databases for studies in English or French examining nonadherence to antihypertensive medications measured by electronic prescription databases where explanatory factors were considered. Two authors independently assessed quality, described the SES measure(s), and recorded its association with nonadherence to antihypertensives. A random-effects model meta-analysis was performed, and heterogeneity was examined by using the I2 statistic. Results Fifty-six studies with 4,780,293 subjects met the inclusion criteria. Twenty-four of these studies (43%) did not report any SES measures. When it was reported (n = 32), only seven (13%) examined more than one component but none performed a multidimensional assessment. Most of the studies relied on income or income-related measures (such as prescription-drug benefits or co-payments) (27 of 32 [84%]). Meta-analysis could be quantified in 40 cohorts reported in 30 studies. Overall, the pooled adjusted risk estimate for nonadherence according to SES (high vs. low) was 0.89 (95% confidence interval 0.87–0.92; I2 = 95%; P < 0.001). Similar patterns were observed in all subgroups examined. Conclusions Published studies have not found a strong association between low SES and nonadherence to antihypertensive medications. However, important limitations in the assessment of SES can be identified in virtually all studies. Future studies are required to ascertain whether a stronger association is observed when SES is determined by comprehensive measures. |
doi_str_mv | 10.1016/j.jval.2013.11.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1541976836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1098301513043969</els_id><sourcerecordid>1508677312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-693dfdc836b7ebaa31fa8566eea45b981a9439cd86b11608e36c429379fe299b3</originalsourceid><addsrcrecordid>eNqNkk-P1CAYhxujcdfVL-DB9GLipZW3tBSM2WSy_k1WTRw9E0rfutQOjEDH9NtLnVETD8YTHJ7fC_wesuwhkBIIsKdjOR7UVFYEaAlQEoBb2Tk0VV3ULaW3054IXlACzVl2L4SREMJo1dzNzqqaUUa5OM-GrdPGoXbW7YzOt1HFOeTK9vl7Z1V_gx6txjy6fGOjuVn26CPaYA6Yv_Dzl_As3-TbJUTcqZjyH_Fg8PvP_DuMqthYNS3BhPvZnUFNAR-c1ovs86uXn67eFNcfXr-92lwXugEeCyZoP_SaU9a12ClFYVC8YQxR1U0nOChRU6F7zjoARjhSputK0FYMWAnR0YvsyXHu3rtvM4YodyZonCZl0c1BQlODaFk64D9QwlnbUqgSWh1R7V0IHge592an_CKByFWFHOWqQq4qJIBMKlLo0Wn-3O2w_x351X0CHp8AFbSaBq-sNuEPx1MlhDSJe37kMBWX6vUyaLNa6Y1HHWXvzL_vcflXXE_GmnTiV1wwjG72SVJ6rwyVJHK7fpr1zwAlqetk5AfWFbwI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1508677312</pqid></control><display><type>article</type><title>Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Alsabbagh, M.H.D. Wasem, BSc ; Lemstra, Mark, PhD ; Eurich, Dean, PhD ; Lix, Lisa M., PhD ; Wilson, Thomas W., MD ; Watson, Erin, MLIS ; Blackburn, David F., PharmD</creator><creatorcontrib>Alsabbagh, M.H.D. Wasem, BSc ; Lemstra, Mark, PhD ; Eurich, Dean, PhD ; Lix, Lisa M., PhD ; Wilson, Thomas W., MD ; Watson, Erin, MLIS ; Blackburn, David F., PharmD</creatorcontrib><description>Abstract Background Although conventional wisdom suggests that low socioeconomic status (SES) is a robust predictor of medication nonadherence, the strength of this association remains unclear. Objectives 1) To estimate the proportion of studies that identified SES as a potential risk indicator of nonadherence, 2) to describe the type of SES measurements, and 3) to quantify the association between SES and nonadherence to antihypertensive pharmacotherapy. Methods A systematic review and meta-analysis research design was used. We searched multiple electronic databases for studies in English or French examining nonadherence to antihypertensive medications measured by electronic prescription databases where explanatory factors were considered. Two authors independently assessed quality, described the SES measure(s), and recorded its association with nonadherence to antihypertensives. A random-effects model meta-analysis was performed, and heterogeneity was examined by using the I2 statistic. Results Fifty-six studies with 4,780,293 subjects met the inclusion criteria. Twenty-four of these studies (43%) did not report any SES measures. When it was reported (n = 32), only seven (13%) examined more than one component but none performed a multidimensional assessment. Most of the studies relied on income or income-related measures (such as prescription-drug benefits or co-payments) (27 of 32 [84%]). Meta-analysis could be quantified in 40 cohorts reported in 30 studies. Overall, the pooled adjusted risk estimate for nonadherence according to SES (high vs. low) was 0.89 (95% confidence interval 0.87–0.92; I2 = 95%; P < 0.001). Similar patterns were observed in all subgroups examined. Conclusions Published studies have not found a strong association between low SES and nonadherence to antihypertensive medications. However, important limitations in the assessment of SES can be identified in virtually all studies. Future studies are required to ascertain whether a stronger association is observed when SES is determined by comprehensive measures.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2013.11.011</identifier><identifier>PMID: 24636389</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adherence ; Antihypertensive Agents - administration & dosage ; Antihypertensive Agents - economics ; Antihypertensive Agents - therapeutic use ; antihypertensive medications ; Biological and medical sciences ; Confidence intervals ; drug adherence ; General aspects ; Heterogeneity ; Humans ; Hypertension - drug therapy ; Hypertension - economics ; Income ; Internal Medicine ; Low income people ; Medical sciences ; Medication Adherence ; Miscellaneous ; Models, Statistical ; pharmacy ; Planification. Prevention (methods). Intervention. Evaluation ; population-level ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Research Design ; Risk Factors ; Social Class ; Socioeconomic status</subject><ispartof>Value in health, 2014-03, Vol.17 (2), p.288-296</ispartof><rights>International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-693dfdc836b7ebaa31fa8566eea45b981a9439cd86b11608e36c429379fe299b3</citedby><cites>FETCH-LOGICAL-c518t-693dfdc836b7ebaa31fa8566eea45b981a9439cd86b11608e36c429379fe299b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jval.2013.11.011$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,30981,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28518005$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24636389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alsabbagh, M.H.D. Wasem, BSc</creatorcontrib><creatorcontrib>Lemstra, Mark, PhD</creatorcontrib><creatorcontrib>Eurich, Dean, PhD</creatorcontrib><creatorcontrib>Lix, Lisa M., PhD</creatorcontrib><creatorcontrib>Wilson, Thomas W., MD</creatorcontrib><creatorcontrib>Watson, Erin, MLIS</creatorcontrib><creatorcontrib>Blackburn, David F., PharmD</creatorcontrib><title>Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis</title><title>Value in health</title><addtitle>Value Health</addtitle><description>Abstract Background Although conventional wisdom suggests that low socioeconomic status (SES) is a robust predictor of medication nonadherence, the strength of this association remains unclear. Objectives 1) To estimate the proportion of studies that identified SES as a potential risk indicator of nonadherence, 2) to describe the type of SES measurements, and 3) to quantify the association between SES and nonadherence to antihypertensive pharmacotherapy. Methods A systematic review and meta-analysis research design was used. We searched multiple electronic databases for studies in English or French examining nonadherence to antihypertensive medications measured by electronic prescription databases where explanatory factors were considered. Two authors independently assessed quality, described the SES measure(s), and recorded its association with nonadherence to antihypertensives. A random-effects model meta-analysis was performed, and heterogeneity was examined by using the I2 statistic. Results Fifty-six studies with 4,780,293 subjects met the inclusion criteria. Twenty-four of these studies (43%) did not report any SES measures. When it was reported (n = 32), only seven (13%) examined more than one component but none performed a multidimensional assessment. Most of the studies relied on income or income-related measures (such as prescription-drug benefits or co-payments) (27 of 32 [84%]). Meta-analysis could be quantified in 40 cohorts reported in 30 studies. Overall, the pooled adjusted risk estimate for nonadherence according to SES (high vs. low) was 0.89 (95% confidence interval 0.87–0.92; I2 = 95%; P < 0.001). Similar patterns were observed in all subgroups examined. Conclusions Published studies have not found a strong association between low SES and nonadherence to antihypertensive medications. However, important limitations in the assessment of SES can be identified in virtually all studies. Future studies are required to ascertain whether a stronger association is observed when SES is determined by comprehensive measures.</description><subject>Adherence</subject><subject>Antihypertensive Agents - administration & dosage</subject><subject>Antihypertensive Agents - economics</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>antihypertensive medications</subject><subject>Biological and medical sciences</subject><subject>Confidence intervals</subject><subject>drug adherence</subject><subject>General aspects</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - economics</subject><subject>Income</subject><subject>Internal Medicine</subject><subject>Low income people</subject><subject>Medical sciences</subject><subject>Medication Adherence</subject><subject>Miscellaneous</subject><subject>Models, Statistical</subject><subject>pharmacy</subject><subject>Planification. Prevention (methods). Intervention. Evaluation</subject><subject>population-level</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Research Design</subject><subject>Risk Factors</subject><subject>Social Class</subject><subject>Socioeconomic status</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkk-P1CAYhxujcdfVL-DB9GLipZW3tBSM2WSy_k1WTRw9E0rfutQOjEDH9NtLnVETD8YTHJ7fC_wesuwhkBIIsKdjOR7UVFYEaAlQEoBb2Tk0VV3ULaW3054IXlACzVl2L4SREMJo1dzNzqqaUUa5OM-GrdPGoXbW7YzOt1HFOeTK9vl7Z1V_gx6txjy6fGOjuVn26CPaYA6Yv_Dzl_As3-TbJUTcqZjyH_Fg8PvP_DuMqthYNS3BhPvZnUFNAR-c1ovs86uXn67eFNcfXr-92lwXugEeCyZoP_SaU9a12ClFYVC8YQxR1U0nOChRU6F7zjoARjhSputK0FYMWAnR0YvsyXHu3rtvM4YodyZonCZl0c1BQlODaFk64D9QwlnbUqgSWh1R7V0IHge592an_CKByFWFHOWqQq4qJIBMKlLo0Wn-3O2w_x351X0CHp8AFbSaBq-sNuEPx1MlhDSJe37kMBWX6vUyaLNa6Y1HHWXvzL_vcflXXE_GmnTiV1wwjG72SVJ6rwyVJHK7fpr1zwAlqetk5AfWFbwI</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Alsabbagh, M.H.D. Wasem, BSc</creator><creator>Lemstra, Mark, PhD</creator><creator>Eurich, Dean, PhD</creator><creator>Lix, Lisa M., PhD</creator><creator>Wilson, Thomas W., MD</creator><creator>Watson, Erin, MLIS</creator><creator>Blackburn, David F., PharmD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QJ</scope></search><sort><creationdate>20140301</creationdate><title>Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis</title><author>Alsabbagh, M.H.D. Wasem, BSc ; Lemstra, Mark, PhD ; Eurich, Dean, PhD ; Lix, Lisa M., PhD ; Wilson, Thomas W., MD ; Watson, Erin, MLIS ; Blackburn, David F., PharmD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-693dfdc836b7ebaa31fa8566eea45b981a9439cd86b11608e36c429379fe299b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adherence</topic><topic>Antihypertensive Agents - administration & dosage</topic><topic>Antihypertensive Agents - economics</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>antihypertensive medications</topic><topic>Biological and medical sciences</topic><topic>Confidence intervals</topic><topic>drug adherence</topic><topic>General aspects</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - economics</topic><topic>Income</topic><topic>Internal Medicine</topic><topic>Low income people</topic><topic>Medical sciences</topic><topic>Medication Adherence</topic><topic>Miscellaneous</topic><topic>Models, Statistical</topic><topic>pharmacy</topic><topic>Planification. Prevention (methods). Intervention. Evaluation</topic><topic>population-level</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Research Design</topic><topic>Risk Factors</topic><topic>Social Class</topic><topic>Socioeconomic status</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alsabbagh, M.H.D. Wasem, BSc</creatorcontrib><creatorcontrib>Lemstra, Mark, PhD</creatorcontrib><creatorcontrib>Eurich, Dean, PhD</creatorcontrib><creatorcontrib>Lix, Lisa M., PhD</creatorcontrib><creatorcontrib>Wilson, Thomas W., MD</creatorcontrib><creatorcontrib>Watson, Erin, MLIS</creatorcontrib><creatorcontrib>Blackburn, David F., PharmD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alsabbagh, M.H.D. Wasem, BSc</au><au>Lemstra, Mark, PhD</au><au>Eurich, Dean, PhD</au><au>Lix, Lisa M., PhD</au><au>Wilson, Thomas W., MD</au><au>Watson, Erin, MLIS</au><au>Blackburn, David F., PharmD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>17</volume><issue>2</issue><spage>288</spage><epage>296</epage><pages>288-296</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>Abstract Background Although conventional wisdom suggests that low socioeconomic status (SES) is a robust predictor of medication nonadherence, the strength of this association remains unclear. Objectives 1) To estimate the proportion of studies that identified SES as a potential risk indicator of nonadherence, 2) to describe the type of SES measurements, and 3) to quantify the association between SES and nonadherence to antihypertensive pharmacotherapy. Methods A systematic review and meta-analysis research design was used. We searched multiple electronic databases for studies in English or French examining nonadherence to antihypertensive medications measured by electronic prescription databases where explanatory factors were considered. Two authors independently assessed quality, described the SES measure(s), and recorded its association with nonadherence to antihypertensives. A random-effects model meta-analysis was performed, and heterogeneity was examined by using the I2 statistic. Results Fifty-six studies with 4,780,293 subjects met the inclusion criteria. Twenty-four of these studies (43%) did not report any SES measures. When it was reported (n = 32), only seven (13%) examined more than one component but none performed a multidimensional assessment. Most of the studies relied on income or income-related measures (such as prescription-drug benefits or co-payments) (27 of 32 [84%]). Meta-analysis could be quantified in 40 cohorts reported in 30 studies. Overall, the pooled adjusted risk estimate for nonadherence according to SES (high vs. low) was 0.89 (95% confidence interval 0.87–0.92; I2 = 95%; P < 0.001). Similar patterns were observed in all subgroups examined. Conclusions Published studies have not found a strong association between low SES and nonadherence to antihypertensive medications. However, important limitations in the assessment of SES can be identified in virtually all studies. Future studies are required to ascertain whether a stronger association is observed when SES is determined by comprehensive measures.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24636389</pmid><doi>10.1016/j.jval.2013.11.011</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1098-3015 |
ispartof | Value in health, 2014-03, Vol.17 (2), p.288-296 |
issn | 1098-3015 1524-4733 |
language | eng |
recordid | cdi_proquest_miscellaneous_1541976836 |
source | MEDLINE; Elsevier ScienceDirect Journals; Applied Social Sciences Index & Abstracts (ASSIA); EZB-FREE-00999 freely available EZB journals |
subjects | Adherence Antihypertensive Agents - administration & dosage Antihypertensive Agents - economics Antihypertensive Agents - therapeutic use antihypertensive medications Biological and medical sciences Confidence intervals drug adherence General aspects Heterogeneity Humans Hypertension - drug therapy Hypertension - economics Income Internal Medicine Low income people Medical sciences Medication Adherence Miscellaneous Models, Statistical pharmacy Planification. Prevention (methods). Intervention. Evaluation population-level Public health. Hygiene Public health. Hygiene-occupational medicine Research Design Risk Factors Social Class Socioeconomic status |
title | Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A42%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Socioeconomic%20Status%20and%20Nonadherence%20to%20Antihypertensive%20Drugs:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Value%20in%20health&rft.au=Alsabbagh,%20M.H.D.%20Wasem,%20BSc&rft.date=2014-03-01&rft.volume=17&rft.issue=2&rft.spage=288&rft.epage=296&rft.pages=288-296&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2013.11.011&rft_dat=%3Cproquest_cross%3E1508677312%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1508677312&rft_id=info:pmid/24636389&rft_els_id=S1098301513043969&rfr_iscdi=true |